Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaMarco L. Davila, Renier J. Brentjens, Oriana Bórquez-Ojeda et al.|Science Translational Medicine|2014Cited by 2.5k
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Marina Konopleva, Nathaniel R. Wilson et al.|Leukemia Research|2022Cited by 18
A Phase I Trial of a Pharmacodynamically-Conceived Decitabine and Thioguanine Combination in Patients with Advanced Myeloid MalignanciesTodd Rosenblat, Mark G. Frattini, Mark Heaney et al.|Blood|2014Cited by 1
A phase I trial of a pharmacodynamically-conceived decitabine/thioguanine combination in patients with advanced myeloid malignancies.Todd Rosenblat, Mark G. Frattini, Joseph G. Jurcic et al.|Journal of Clinical Oncology|2015Cited by 0